Closing the women’s health gap: Biopharma’s untapped opportunity

Most top pharma companies derive more than 60 percent of their revenue from therapies for diseases that affect women uniquely, differently, or disproportionately, putting them in a prime position to close the sex- and gender-based health gap.

Feb 9, 2025 - 21:48
 0
Closing the women’s health gap: Biopharma’s untapped opportunity
Most top pharma companies derive more than 60 percent of their revenue from therapies for diseases that affect women uniquely, differently, or disproportionately, putting them in a prime position to close the sex- and gender-based health gap.